AGN: Summary for Allergan plc Ordinary Shares - Yahoo Finance

UK Markets close in 5 hrs 20 mins

Allergan plc (AGN)


NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
214.82+0.48 (+0.22%)
At close: 4:02PM EST

216.77 1.95 (0.91%)
Pre-market: 4:11AM EST

People also watch
BIIBCELGVRXGILDREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close214.34
Open212.43
Bid0.00 x
Ask0.00 x
Day's range211.11 - 218.08
52-week range184.50 - 301.32
Volume3,877,588
Avg. volume5,239,838
Market cap80.57B
Beta1.12
PE ratio (TTM)6.02
EPS (TTM)N/A
Earnings dateN/A
Dividend & yield2.80 (1.31%)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Endo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed
    Investor's Business Daily14 hours ago

    Endo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed

    Endo agreed to a 10-year settlement with the FTC on Monday, resolving a suit that alleges Endo paid Allergan to prevent it from launching a generic.

  • Investopedia15 hours ago

    Allergan Stock is Still Struggling Amid FTC Ruling

    Endo Pharmaceuticals agrees to abandon "pay-for-delay." Allergan and Teva move lower in sympathy.

  • Reuters15 hours ago

    FTC settles pay-for-delay lawsuit, files two related complaints

    The U.S. Federal Trade Commission said on Monday it had settled allegations that Endo Pharmaceuticals violated antitrust law when it agreed to pay rivals Watson Laboratories and Impax to delay introducing generic versions of two painkillers. The FTC filed charges against Watson, and Allergan Plc , accusing it of breaking the law by reaching an agreement with Endo to block a generic competitor for the local anesthetic Lidoderm. The FTC also filed an administrative complaint against Impax, saying it reached an illegal agreement with Endo in 2010 to prevent Impax from marketing a generic copy of Endo's painkiller Opana ER.